| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,556 |
17,458 |
$3.20M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,465 |
5,429 |
$1.55M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,558 |
1,554 |
$644K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
965 |
954 |
$152K |
| 87428 |
|
3,794 |
3,779 |
$142K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
526 |
524 |
$55K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
692 |
614 |
$41K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
484 |
471 |
$28K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,694 |
1,688 |
$25K |
| 81003 |
|
3,525 |
3,503 |
$19K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,151 |
2,131 |
$14K |
| 80051 |
|
1,717 |
1,697 |
$13K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
162 |
162 |
$11K |
| 81025 |
|
1,499 |
1,487 |
$11K |
| 82550 |
|
1,705 |
1,686 |
$10K |
| 82565 |
|
1,718 |
1,698 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
466 |
235 |
$7K |
| 82947 |
|
1,782 |
1,741 |
$6K |
| 84520 |
|
1,700 |
1,681 |
$6K |
| 82977 |
|
921 |
916 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
421 |
421 |
$6K |
| 82150 |
|
942 |
936 |
$5K |
| 84460 |
|
927 |
921 |
$4K |
| 84075 |
|
927 |
921 |
$4K |
| 84450 |
|
927 |
921 |
$4K |
| 82247 |
|
929 |
923 |
$4K |
| 82040 |
|
929 |
923 |
$4K |
| 87420 |
|
243 |
243 |
$3K |
| 84155 |
|
929 |
923 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
57 |
55 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13 |
13 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
45 |
44 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$2K |
| 87400 |
|
61 |
52 |
$1K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
12 |
12 |
$1K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
166 |
162 |
$856.87 |
| 71046 |
Radiologic examination, chest; 2 views |
29 |
29 |
$551.05 |
| 84484 |
|
26 |
24 |
$343.79 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
38 |
38 |
$328.02 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
28 |
28 |
$208.22 |
| 80305 |
|
13 |
13 |
$145.73 |
| 87807 |
|
12 |
12 |
$139.80 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
13 |
13 |
$108.00 |
| 87070 |
|
12 |
12 |
$102.24 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13 |
13 |
$97.89 |
| 87088 |
|
12 |
12 |
$86.40 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
77 |
75 |
$21.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
102 |
93 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16 |
16 |
$0.00 |